• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.

作者信息

Zundel Michael T, Feih Joel T, Rinka Joseph R G, Boettcher Brent T, Freed Julie K, Kaiser Markus, Ghadiali Huzefa Y, Tawil Justin N, Woehlck Harvey J, Pagel Paul S

机构信息

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI.

Department of Pharmacy, Medical College of Wisconsin, Milwaukee, WI.

出版信息

J Cardiothorac Vasc Anesth. 2018 Feb;32(1):452-457. doi: 10.1053/j.jvca.2017.04.002. Epub 2017 Apr 5.

DOI:10.1053/j.jvca.2017.04.002
PMID:28778773
Abstract
摘要

相似文献

1
Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.心脏手术后患有血管麻痹综合征的危重症患者使用或不使用亚甲蓝的羟钴胺素可能改善液体平衡：两例报告
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):452-457. doi: 10.1053/j.jvca.2017.04.002. Epub 2017 Apr 5.
2
The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.静脉注射羟钴胺素在心脏手术中对亚甲蓝抵抗性血管麻痹综合征的抢救应用。
Ann Card Anaesth. 2017 Oct-Dec;20(4):462-464. doi: 10.4103/aca.ACA_88_17.
3
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。
Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.
4
Methylene Blue for Vasoplegic Syndrome.亚甲蓝治疗血管麻痹综合征
Heart Surg Forum. 2017 Oct 31;20(5):E234-E238. doi: 10.1532/hsf.1806.
5
Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.羟钴胺素治疗血管麻痹：当前文献综述及使用考量
J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.
6
Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.心脏手术患者血管麻痹综合征：文献综述。
AACN Adv Crit Care. 2021 Jun 15;32(2):137-145. doi: 10.4037/aacnacc2021299.
7
Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.用于肝移植中血管麻痹综合征的羟钴胺：恢复血压且无血管痉挛
A A Case Rep. 2016 Dec 15;7(12):247-250. doi: 10.1213/XAA.0000000000000398.
8
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.亚甲蓝单药治疗与羟钴胺联合治疗难治性血管扩张性休克的疗效比较：一项回顾性队列研究。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1301-1307. doi: 10.1053/j.jvca.2018.11.020. Epub 2018 Nov 16.
9
[Methylene blue therapy for vasoplegia after cardiac surgery].[亚甲蓝治疗心脏手术后血管麻痹]
Anestezjol Intens Ter. 2009 Jul-Sep;41(3):159-62.
10
Intraoperative vasoplegia: methylene blue to the rescue!术中血管麻痹：亚甲蓝来救援！
Curr Opin Anaesthesiol. 2018 Feb;31(1):43-49. doi: 10.1097/ACO.0000000000000548.

引用本文的文献

1
The Durability of Intravenous Hydroxocobalamin in Vasoplegia.静脉注射羟钴胺治疗血管麻痹的疗效持久性
Cureus. 2023 Apr 29;15(4):e38307. doi: 10.7759/cureus.38307. eCollection 2023 Apr.
2
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。
Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.
3
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.
羟钴胺在左心室辅助装置患者血管麻痹综合征中的应用。
Clin Case Rep. 2020 Jun 26;8(9):1722-1727. doi: 10.1002/ccr3.2967. eCollection 2020 Sep.
4
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.心胸外科手术后血管麻痹综合征：病理生理学综述及治疗选择更新。
Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.
5
Development of a severe mesenteric traction syndrome during major abdominal surgery is associated with increased postoperative morbidity: Secondary data analysis on prospective cohorts.在大型腹部手术中发生严重肠系膜牵引综合征与术后发病率增加相关：前瞻性队列的二次数据分析。
Langenbecks Arch Surg. 2020 Feb;405(1):81-90. doi: 10.1007/s00423-019-01847-1. Epub 2019 Dec 9.